“Roger Klein, a consultant and an expert on the FDA and Health Working Group that is part of the Federalist Society’s Regulatory and Transparency Project, said the pharmacy concession policy is difficult to figure out and the administration wants to avoid unintended consequences. Klein assumes CMS officials put forth the policy as an informal proposal because it isn’t crystalized and they want to get more feedback. ‘I think they’re acting in good faith,’ Klein said.” (Originally posted 1 week ago) https://insidehealthpolicy.com/no-access